NO20030699D0 - Fremgangsmåte for fremstilling av cilostazol - Google Patents
Fremgangsmåte for fremstilling av cilostazolInfo
- Publication number
- NO20030699D0 NO20030699D0 NO20030699A NO20030699A NO20030699D0 NO 20030699 D0 NO20030699 D0 NO 20030699D0 NO 20030699 A NO20030699 A NO 20030699A NO 20030699 A NO20030699 A NO 20030699A NO 20030699 D0 NO20030699 D0 NO 20030699D0
- Authority
- NO
- Norway
- Prior art keywords
- cilostazole
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22536200P | 2000-08-14 | 2000-08-14 | |
| PCT/US2001/025398 WO2002014283A1 (en) | 2000-08-14 | 2001-08-14 | Processes for preparing cilostazol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030699D0 true NO20030699D0 (no) | 2003-02-13 |
| NO20030699L NO20030699L (no) | 2003-04-10 |
Family
ID=22844569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030699A NO20030699L (no) | 2000-08-14 | 2003-02-13 | Fremgangsmåte for fremstilling av cilostazol |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1311485A4 (no) |
| JP (2) | JP3845059B2 (no) |
| KR (1) | KR20030024865A (no) |
| CN (1) | CN1469864A (no) |
| AU (1) | AU2001284887A1 (no) |
| CA (1) | CA2419181A1 (no) |
| CZ (1) | CZ2003667A3 (no) |
| HK (1) | HK1053116A1 (no) |
| HU (1) | HUP0302688A2 (no) |
| IL (1) | IL154458A0 (no) |
| IS (1) | IS6716A (no) |
| MX (1) | MXPA03001470A (no) |
| NO (1) | NO20030699L (no) |
| NZ (1) | NZ524363A (no) |
| PL (1) | PL365672A1 (no) |
| SK (1) | SK2992003A3 (no) |
| WO (1) | WO2002014283A1 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030045547A1 (en) | 2001-05-02 | 2003-03-06 | Shinji Aki | Process for producing carbostyril derivatives |
| US20050101631A1 (en) | 2002-08-01 | 2005-05-12 | Otsuka Pharmaceuticals Company | Process for producing carbostyril derivatives |
| US7399864B2 (en) | 2001-05-02 | 2008-07-15 | Otsuka Pharmaceutical Co., Ltd. | Process for producing carbostyril derivatives |
| PT1489080E (pt) * | 2002-09-10 | 2011-02-16 | Otsuka Pharma Co Ltd | Processo para produzir cilostazol |
| EP1765782A1 (en) | 2004-02-05 | 2007-03-28 | Teva Pharmaceutical Industries Ltd | Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril |
| KR100633232B1 (ko) * | 2004-08-25 | 2006-10-11 | 주식회사유한양행 | 신규한 6-[4-(1-시클로헥실-1ｈ-테트라졸-5-일)부톡시]-3,4-디히드로-2(1ｈ)-퀴놀리논 정제방법 |
| US20070270590A1 (en) * | 2006-04-20 | 2007-11-22 | Marioara Mendelovici | Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
| TW200848041A (en) | 2007-03-30 | 2008-12-16 | Otsuka Pharma Co Ltd | A medicament for treating schizophrenia comprising cilostazol |
| EP2152689B1 (en) | 2007-04-25 | 2013-01-02 | Concert Pharmaceuticals Inc. | Analogues of cilostazol |
| CN101434598B (zh) * | 2008-12-19 | 2012-11-07 | 重庆康乐制药有限公司 | 西洛他唑的制备方法 |
| CN102086190B (zh) * | 2011-01-28 | 2013-07-10 | 海南美兰史克制药有限公司 | 西洛他唑化合物及其制法 |
| CN107382970A (zh) * | 2017-07-26 | 2017-11-24 | 浙江金立源药业有限公司 | 一种西洛他唑的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5535019A (en) * | 1978-09-01 | 1980-03-11 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| JPH01265051A (ja) * | 1988-04-14 | 1989-10-23 | Fuji Photo Film Co Ltd | ジアリールオキシアルカン製造方法 |
-
2001
- 2001-08-14 CA CA002419181A patent/CA2419181A1/en not_active Abandoned
- 2001-08-14 WO PCT/US2001/025398 patent/WO2002014283A1/en not_active Application Discontinuation
- 2001-08-14 KR KR10-2003-7002140A patent/KR20030024865A/ko not_active Application Discontinuation
- 2001-08-14 EP EP01963979A patent/EP1311485A4/en not_active Withdrawn
- 2001-08-14 SK SK299-2003A patent/SK2992003A3/sk unknown
- 2001-08-14 NZ NZ524363A patent/NZ524363A/en unknown
- 2001-08-14 HU HU0302688A patent/HUP0302688A2/hu unknown
- 2001-08-14 CZ CZ2003667A patent/CZ2003667A3/cs unknown
- 2001-08-14 PL PL01365672A patent/PL365672A1/xx unknown
- 2001-08-14 AU AU2001284887A patent/AU2001284887A1/en not_active Abandoned
- 2001-08-14 CN CNA018172083A patent/CN1469864A/zh active Pending
- 2001-08-14 JP JP2002519426A patent/JP3845059B2/ja not_active Expired - Fee Related
- 2001-08-14 MX MXPA03001470A patent/MXPA03001470A/es unknown
- 2001-08-14 IL IL15445801A patent/IL154458A0/xx unknown
-
2003
- 2003-02-13 NO NO20030699A patent/NO20030699L/no not_active Application Discontinuation
- 2003-02-13 IS IS6716A patent/IS6716A/is unknown
- 2003-07-25 HK HK03105399.3A patent/HK1053116A1/zh unknown
-
2005
- 2005-06-21 JP JP2005181031A patent/JP2005350474A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL365672A1 (en) | 2005-01-10 |
| WO2002014283A1 (en) | 2002-02-21 |
| AU2001284887A1 (en) | 2002-02-25 |
| CZ2003667A3 (cs) | 2003-08-13 |
| EP1311485A1 (en) | 2003-05-21 |
| IS6716A (is) | 2003-02-13 |
| EP1311485A4 (en) | 2004-05-12 |
| MXPA03001470A (es) | 2005-06-30 |
| HUP0302688A2 (hu) | 2003-12-29 |
| JP2004506043A (ja) | 2004-02-26 |
| NO20030699L (no) | 2003-04-10 |
| CN1469864A (zh) | 2004-01-21 |
| HK1053116A1 (zh) | 2003-10-10 |
| KR20030024865A (ko) | 2003-03-26 |
| IL154458A0 (en) | 2003-09-17 |
| NZ524363A (en) | 2004-03-26 |
| JP2005350474A (ja) | 2005-12-22 |
| JP3845059B2 (ja) | 2006-11-15 |
| CA2419181A1 (en) | 2002-02-21 |
| SK2992003A3 (en) | 2003-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030012L (no) | Fremgangsmåte for fremstilling av substituerte oktanoylamider | |
| ATE296100T1 (de) | Cilostazol enthaltende zubereitung | |
| CY2007029I1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| NO20042680L (no) | Fremgangsmater for fremstilling av O-demetylvenflaxine | |
| FI20000564A (fi) | Menetelmä nanolaminaattien valmistamiseksi | |
| NO20013942D0 (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20031229L (no) | Fremgangsmåte for fremstilling av börstevarer | |
| NO20030163L (no) | Fremgangsmate for fremstilling av olefiner | |
| NO20033433D0 (no) | Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol | |
| NO20032731D0 (no) | Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner | |
| NO20030699L (no) | Fremgangsmåte for fremstilling av cilostazol | |
| NO20042640L (no) | Fremgangsmate for fremstilling av ekinocandinderivater | |
| NO20031413D0 (no) | Ny fremgangsmåte for fremstilling av oksabispidiner | |
| NO20035538D0 (no) | Fremgangsmåte for fremstilling av zaleplon | |
| NO20025423L (no) | Fremgangsmate for fremstilling av Citalopram | |
| NO20026155D0 (no) | Fremgangsmåte for fremstilling av lavere olefiner | |
| NO20021118D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
| NO20030515D0 (no) | Fremgangsmåte for fremstilling av dinapsolin | |
| HUP0300703A3 (en) | Process for the preparation of quinoline derivatives | |
| NO20013407D0 (no) | Fremgangsmåte for fremstilling av kinolinkarbaldehyd | |
| NO20030717L (no) | Forbindelser for behandling av avhengighetsforstyrrelser | |
| NO20024887L (no) | FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser | |
| NO20023577L (no) | Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider | |
| NO20023702L (no) | Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder | |
| NO20032297D0 (no) | Fremgangsmåte for fremstilling av distamycinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |